Inventor · disambiguated record
Wolfgang Halfbrodt
Also filed as: HALFBRODT WOLFGANG
15 granted patents·3 pending applications·76 citations·filing 1993–2025
90Inventor score
Top patents by PatentIndex Score
18 records- 0189US6855714B21-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivativesSCHERING AG·Filed 2002·Granted Feb 15, 2005·29 cites·14 claims
- 0285US7345075B21,2 diarylbenzimidazoles and their pharmaceutical useSCHERING AG·Filed 2005·Granted Mar 18, 2008·5 cites·20 claims
- 0382US7115645B21,2 diarylbenzimidazoles and their pharmaceutical useSCHERING AG·Filed 2001·Granted Oct 3, 2006·22 cites·18 claims
- 0481US12303573B2Formulation of contrast media and process of preparation thereofBAYER AG·Filed 2024·Granted May 20, 2025·0 cites·14 claims
- 0581US7329679B21,2 Diarylbenzimidazoles and their pharmaceutical useSCHERING AG·Filed 2005·Granted Feb 12, 2008·3 cites·32 claims
- 0673US6962932B21-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivativesSCHERING AG·Filed 2003·Granted Nov 8, 2005·6 cites·18 claims
- 0770US11944690B2Formulation of contrast media and process of preparation thereofBAYER AG·Filed 2019·Granted Apr 2, 2024·0 cites·14 claims
- 0864US2025152753A1Formulation of contrast media and process of preparation thereofBAYER AG·Filed 2025·Application pending·0 cites
- 0958US2006211690A1Microglia inhibitors for interrupting interleukin 12 and IFNgamma-mediated immune reactionsSCHERING AG·Filed 2006·Application pending·0 cites
- 1054US7683081B21-phenyl-2-heteroaryl-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivativesBAYER SCHERING PHARMA AG·Filed 2005·Granted Mar 23, 2010·0 cites·21 claims
- 1154US7196202B21-aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivativesSCHERING AG·Filed 2005·Granted Mar 27, 2007·0 cites·14 claims
- 1254US2004006117A1Microglia inhibitors for interrupting interleukin 12 and IFN-gamma-mediated immune reactionsSCHERING AG·Filed 2003·Application pending·0 cites
- 1347US5827842A14α, 17α-C2 -bridged norprogesterone derivativesSCHERING AG·Filed 1995·Granted Oct 27, 1998·6 cites·14 claims
- 1446US6903126B21-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivativesSCHERING AG·Filed 2002·Granted Jun 7, 2005·0 cites·14 claims
- 1543US5523298AProgestationally active 19,11-bridged 4-estrenesSCHERING AG·Filed 1993·Granted Jun 4, 1996·4 cites·10 claims
- 1635US5703066AProgestationally active 19,11-bridged 4-estrenesSCHERING AG·Filed 1995·Granted Dec 30, 1997·1 cites·13 claims
- 1731US6147065A14-α, 17-α-C2 bridged norprogesterone derivativesSCHERING AG·Filed 1999·Granted Nov 14, 2000·0 cites·30 claims
- 1825US5973172A14-α,17-α-C2 -bridged norprogesterone derivativesSCHERING AKITENGESELLSCHAFT·Filed 1998·Granted Oct 26, 1999·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Wolfgang Halfbrodt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →